Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling

Archives of Surgery

Volumn 143, Issue 9, 2008, Pages 841-846

  Fernandez Ranvier, Gustavo G ^a   Weng, Julie ^a   Yeh, Ru Fang ^b   Khanafshar, Elham ^b   Suh, Insoo ^a   Barker, Christopher ^b   Duh, Quan Yang ^a   Clark, Orlo H ^a,c   Kebebew, Electron ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

ADOLESCENT; ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; ADULT; AGED; AREA UNDER CURVE; CHEMOKINES; CYCLIN B; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-13 RECEPTOR ALPHA2 SUBUNIT; MALE; MIDDLE AGED; MONOCARBOXYLIC ACID TRANSPORTERS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PITUITARY ACTH HYPERSECRETION; RECEPTOR, SEROTONIN, 5-HT2B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 52249109610     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.143.9.841     Document Type: Article

References (24)

1. Lee J, Kebebew E.Adrenocortical tumors. In: Cameron JL, ed. Current Surgical Therapy. 9th ed. Philadelphia, Pa: Mosby Elsevier: 2008:583-592.
2. Latronico AC, Chrousos GP. Extensive personal experience: adrenocortical tumors. J Clin Endocrinol Metab. 1997;82(5):1317-1324.
3. Icard P, Goudet P, Charpenay C, et al. Adren ocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg. 2001 ;25(7):891-897.
4. Favia G, Lumachi F, Carraro P, et al. Adrenocortical carcinoma: our experience. Minerva Endocrinol. 1995;20(1):95-99.
5. Kebebew E, Reiff E, Duh QY, et al. Extent of disease at presentation and outcome for ad renocortical carcinoma: have we made progress? World J Surg. 2006; 30(5):872-878.
6. Sturgeon C, Shen WT, Clark OH, et al. Risk assessment In 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy? J Am Coll Surg 2006;202(3):423-430.
7. Giordano TJ, Thomas DG, Kuick R, et al. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am J Pathol. 2003; 162(2):521-531.
8. de Fraipont F, El Atifi M, Cherradi N, et al. Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microar-rays identifies several candidate genes as markers of malignancy. J Clin Endocrinol Metab. 2005;90(3):1819-1829.
9. Velázquez-Fernández D. Laurell C, Geli J, et al. Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy. Surgery. 2005; 138(6):1087-1094.
10. Slater EP, Diehl SM, Langer P, et al. Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors. Eur J Endocrinol. 2006: 154(4):587-598.
11. Irizarry RA, Bolstad BM, Collin F, et al. Summaries of Affymetrix GeneChip probe level data. Hucleic Acids Res. 2003;31(4):e15 http://nar.oxfordjournals.org/cgi /content/full/31/4/e15. Accessed April 1, 2008.
12. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004: 5(10):R80.
13. Bolstad BM, Irizarry RA, Astrand M, et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19(2):185-193.
14. Smyth GK. Linear models and empirical bayes methods for assessing differential expression In microarray experiments. Stat Appl Genet Mol Biol. 2004; 3:Article3.
15. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate In behavior genetics research. BehavBrain Res. 2001 ;125(1-2):279-284.
16. Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature. 2005:436(7050):518-524.
17. Vicaut E, Laemmel E, Stücker 0. Impact of serotonin on tumour growth. Ann Med. 2000;32(3):187-189.
18. Stav D. Bar I, Sandbank J. Usefulness of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung adenocarcinoma. Int J Biol Markers. 2007;22(2):108-113.
19. Kirikoshi H, Katoh M. Molecular cloning and characterization of human GIPC2, a novel gene homologous to human GIPC1 and Xenopus Kermit. Int J Oncol. 2002; 20(3):571-576.
20. Siritantikorn A, Johansson K, Ahlen K, et al. Protection of cells from oxidative stress by microsomal glutathi one transferase 1. Biochem Biophys Res Commun. 2007;355(2):592-596.
21. Bogerd HP, Wiegand HL, Doehle BP, et al. APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function In human cells. Nucleic Acids Res. 2006;34(1):89-95.
22. Xu R, Zhang X, Zhang W, et al. Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocel-lular carcinoma. Hepatology. 2007;46(6):1810-1820.
23. West AN, Neale GA, Pounds S, et al. Gene expression profiling of childhood ad-ren ocortical tumors. Cancer Res. 2007;67(2):600-608.
24. Arriola E, Rod riguez-Pinilla SM, Lambros MB, et al.Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer. Breast Cancer Res Treat. 2007;106(2)181-189.